Lyme Disease Diagnostics Comprehensive Study by Diagnostic Technology (Serological Test (ELISA, Western Blot), Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic acid Test), End User (Hospitals, Public/Private Laboratories, Others) Players and Region - Global Market Outlook to 2024

Edison , NJ -- (SBWire) -- 04/20/2019 --Lyme disease is a tick-borne infectious disease caused by Borrelia burgdorferi. Common symptoms of the Lyme disease are flu-like symptoms, rashes, bulls-eye pattern, weakness in the limbs, and joint pain. Rise in a number of patients with Lyme disease driving the demand for Lyme disease diagnostic market. For instance, according to the Centers for Disease Control and Prevention (CDC) every year, approximately 30,000 cases of Lyme disease are reported in the United States. Further, increasing investment in healthcare infrastructure in developing countries expected to drive the demand for Lyme disease diagnostic market over the forecasted period.

Advance Market Analytics recently introduced Lyme Disease Diagnostics Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2024. Lyme Disease Diagnostics Market explores effective study on varied sections of Industry like opportunities, size, growth, technology, demand and trend of high leading players. It also provides market key statistics on the status of manufacturers, a valuable source of guidance, direction for companies and individuals interested in the industry.

Get Free PDF Sample Pages of Lyme Disease Diagnostics Market Report:
https://www.advancemarketanalytics.com/sample-report/88675-global-lyme-disease-diagnostics-market

Major Key Players in This Report Include,
Abbott Laboratories (United States), T2 Biosystems (United States), Canon Life Sciences (United States), Bio-Rad Laboratories (United States), Alere Inc. (United States), Roche Diagnostics International Ltd. (Switzerland), Graphene Frontiers (United States), Covance Inc. (United States), GlaxoSmithKline Pharmaceuticals Ltd. (India), Boulder Diagnostics (United States) and Thermo Fisher Scientific (United States).

The report focuses on Global Lyme Disease Diagnostics Market major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the market development trends and marketing channels are analyzed.

Market Highlights:

"The Centers for Disease Control and Prevention (CDC) has developed a national Lyme disease risk map in which CDC identified areas of the United States as minimal or no risk, low risk, moderate risk, or high risk for predicted Lyme disease."

The market study is being classified by Type, by Application and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

The research methodology used to estimate and forecast the Lyme Disease Diagnostics Market began with capturing data from the key vendors' revenue and market size of the individual segments through secondary sources, industry associations, and trade journals, such as the World Analytics Association and the Cloud Native Computing Foundation. The bottom-up procedure was employed to arrive at the overall market size of the market from the individual segments. After arriving at the overall market size, the total market was split into several segments and sub segments, which were then verified through primary research by conducting extensive interviews with the key industry personnel, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), directors, and executives. The data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all the segments and sub segments.

For Early Buyers | Get Up to 20% Discount on This Premium Report:
https://www.advancemarketanalytics.com/request-discount/88675-global-lyme-disease-diagnostics-market

Strategic Points Covered in Table of Content of Lyme Disease Diagnostics Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Lyme Disease Diagnostics market
Chapter 2: Exclusive Summary – the basic information of the Lyme Disease Diagnostics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Lyme Disease Diagnostics
Chapter 4: Presenting the Lyme Disease Diagnostics Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region 2013-2018
Chapter 6: Evaluating the leading manufacturers of the Lyme Disease Diagnostics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Lyme Disease Diagnostics Market is a valuable source of guidance for individuals and companies.

Data Sources & Methodology

The primary sources involves the industry experts from the Lyme Disease Diagnostics Market including the management organizations, processing organizations, analytics service providers of the industry's value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.

In the extensive primary research process undertaken for this study, the primary sources – Postal Surveys, telephone, Online & Face-to-Face Survey were considered to obtain and verify both qualitative and quantitative aspects of this research study. When it comes to secondary sources Company's Annual reports, press Releases, Websites, Investor Presentation, Conference Call transcripts, Webinar, Journals, Regulators, National Customs and Industry Associations were given primary weight-age.

For More Information and Customization:
https://www.advancemarketanalytics.com/enquiry-before-buy/88675-global-lyme-disease-diagnostics-market

Contact Us:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@advancemarketanalytics.com

Connect with us at
https://www.linkedin.com/company/advance-market-analytics
https://www.facebook.com/AMA-Research-Media-LLP-344722399585916
https://twitter.com/amareport